A synthetic heptadecapeptide, CKS-17, represents the highly conserved amino acid sequences occurring within the transmembrane envelope protein of many animal and human retroviruses. CKS-17 has been demonstrated to exhibit suppressive properties for numerous immune functions. We have recently shown that CKS-17 acts as an immunomodulatory epitope causing an imbalance of human type 1 and type 2 cytokine production and suppression of cellmediated immunities. cAMP, an intracellular second messenger, plays an important role in regulation of cytokine biosynthesis-i.e., elevation of intracellular cAMP levels selectively inhibits type 1 cytokine production but has no effect or enhances type 2 cytokine production. Here, we demonstrate that CKS-17 induces dramatic rises in the intracellular cAMP levels of a human monocyte cell line and of human peripheral blood mononuclear cells in a time-and dose-dependent manner. A peptide corresponding to the reverse sequence of CKS-17, used as control, has no effect on intracellular cAMP levels. The cAMP-inducing ability of CKS-17 is significantly blocked by SQ-22536, an inhibitor of adenylate cyclase. These results indicate that CKS-17, a highly conserved component of the transmembrane proteins of immunosuppressive retroviruses, induces increased intracellular levels of cAMP via activation of adenylate cyclase and suggest that this retroviral envelope peptide may differentially modulate type 1 and type 2 cytokine production through elevation of intracellular cAMP levels.
cAMP levels.
Retroviral infection causes severe immunosuppression, leading to fatal disorders in a variety of species (1-3). However, the exact cause of the generalized immunodysfunction associated with retroviral infection remains enigmatic. Viral components have been shown to be associated with and produce dramatic immunosuppressive effects, strongly supporting the view that viral components are relevant to the pathology and progression of retroviral infectious diseases (2-7). A transmembrane envelope protein, pl5E, of feline and murine leukemia viruses is one of the retroviral structural components that exert immunosuppressive activities even when human cells are used as target (2, 3).
We have investigated the mechanism(s) of retrovirusinduced immunodeficiency using a pl5E-related synthetic peptide, (3, (7) (8) (9) (10) (11) (12) (13) (14) . CKS-17 is a heptadecapeptide homologous to the highly conserved amino acid sequences within the transmembrane envelope protein of several animal and human retroviruses (15) (16) (17) . Recently, we demonstrated that this retroviral envelope peptide, CKS-17, differentially modulates human type 1 and type 2 cytokine expression and
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. may act as an immunomodulatory epitope responsible for cytokine dysregulation that leads to suppression of cellular immunity (14). Our data show that CKS-17 suppresses type 1 cytokines, interleukin (IL) 2, IL-12, and interferon 'y, while consistently enhancing a type 2 cytokine, IL-10. CKS-17 does not suppress type 2 cytokines such as IL-4, IL-5, IL-6, IL-10, and IL-13. Our studies further show that CKS-17 acts directly on monocytes and down-regulates transcriptional activation of the tumor necrosis factor (TNF-a) gene (13). The reduced production of IL-12 and TNF-a and enhanced IL-10 production from monocytes/macrophages may cause an imbalance in type 1 and type 2 cytokine production and influence cellmediated immunity in a negative manner.
Well-established evidence indicates that cAMP, an important intracellular second messenger, exerts modulating effects on various immune functions (18) . Recent findings using human and mouse T cells/T-cell clones, monocytes/macrophages, and peripheral blood mononuclear cells (PBMC) have shown that an increase in intracellular cAMP levels results in inhibition of IL-2, IL-12, and interferon y production but not of IL-4, IL-5, IL-6, and IL-10 production. An increase in cAMP may be associated with an up-regulation of the latter group of cytokines (19-27, 29, 39) . These results indicate that signaltransduction pathways for gene expression of type 1 and type 2 cytokines differ in sensitivity to an intracellular increase in cAMP levels. It has also been demonstrated that Th2 cell lines maintain significantly higher levels of cAMP per cell than a Thl cell line (21) and that an increase in intracellular cAMP levels inhibits TNF-a production by T cells, monocytes, and PBMC (24, 25, 28, 29) .
In an effort to understand some of the mechanism(s) by which retroviruses influence immune phenomena, the present studies were designed to analyze the influence of CKS-17 on intracellular cAMP levels of a human monocyte cell line, THP-1, and of human PBMC. Fig. 1 shows that intracellular cAMP levels were remarkably induced by MN21 in a time-dependent manner, and the cAMP level reached a maximum between 15 and 30 min after treatment of THP-1 cells with MN21. The control peptide, MN50, had no effect on the intracellular cAMP levels. Fig. 2 shows the results of MN21 dose-response experiments. THP These results clearly show that MN21 induces increased intracellular levels of cAMP through adenylate cyclase activation.
MATERIAL AND METHODS
Discussion and Concluding Remarks. It is well known that membrane-associated heterotrimeric guanine nucleotidebinding proteins (G proteins) control the turnover of cAMP by regulating adenylate cyclase activity (32) . Possible interpretation of the present observations is that MN21 activates adenylate cyclase through a receptor that couples it to G proteins. Although pl5E has been shown to directly bind to surfaces of human cells (33) , a receptor for CKS- 17 has not yet been demonstrated. Another mechanism would be that internalized MN21 activates adenylate cyclase directly.
Our prior studies (12-14) have shown that CKS-17 suppresses TNF-a and IL-12 expression while enhancing IL-10 expression and that CKS-17-induced inhibition of IL-12 p40 heavy-chain mRNA expression is independent of enhancement of IL-10 production by CKS-17. Because it has been shown that cAMP-elevating agents inhibit TNF-a (24, 29) and IL-12 (39) production but enhance IL-10 production in monocytes/macrophages (29) or whole blood (39) , the present results suggest that CKS-17 mediates its effects on the TNF-a Table 1 . Inhibition of MN21 cAMP-inducing activity by SQ-22536, an inhibitor of adenylate cyclase and IL-10 genes by elevating intracellular cAMP levels. The gene expression of IL-12 p40 heavy chain as well as TNF-a may be regulated by a cAMP-sensitive signal-transduction pathway, whereas the signaling pathway(s) for IL-10 gene expression may be positively regulated by cAMP.
Understanding the exact molecular mechanism(s) whereby CKS-17 exhibits such differential effects on TNF-a, IL-12 p40 heavy chain, and IL-10 mRNA expression is a further subject of interest. Recently, it has been shown that cAMP-dependent pathways may antagonize calcineurin-regulated cascades for IL-2 gene transcription (34) . Calcineurin, a Ca2+/calmodulindependent serine/threonine protein phosphatase, has been found to stimulate a nuclear transcription factor, NF-KB, by enhancing inactivation of IKB-a/MAD3, an inhibitor of NF-KB (35) . It has also been demonstrated that calcineurin participates in the induction of TNF-a gene transcription in T and B cells (36) and that consensus DNA-binding motifs for NF-KB proteins exist in the regulatory region of the TNF-a gene (37) . In the light of these reports one simple interpretation of our findings may be that elevated levels of intracellular cAMP by CKS-17 antagonizes calcineurin, which then suppresses NF-KB induction and leads to inhibition of TNF-a gene transcription.
In conclusion, the present study shows that this highly conserved retroviral octadecapeptide induces remarkable levels of intracellular cAMP via stimulation of adenylate cyclase in a human monocyte cell line -and in human PBMC. cAMP controls physiologic cellular responses, such as cell growth and differentiation, as well as immune effector functions (18) . Of interest in this context, human immunodeficiency virus proteins have been recently shown to impair lymphocyte proliferation by induction of intracellular cAMP levels (38) . Hence, CKS-17, highly conserved among various retroviral envelope components, could affect several physiologic cellular functions, as well as cytokine gene expression, by increasing intracellular levels of cAMP. Our observations may thus be relevant to understanding the molecular mechanism(s) by which retrovirus infections influence cellular functions, including immune functions. 
